Homeland Integrated Security Systems Signs Exclusive Distribution Agreement
with Implant Sciences CyberNoze to Distribute Explosives Detection Equipment
for Security Threats In Lebanon
ASHEVILLE, N.C., Jul 19, 2005 (PRIMEZONE via COMTEX) -- Homeland Integrated
Security Systems, Inc. (Pink Sheets:HISC), a leading provider of wireless
security solutions and products for national security and industry, announced
today the execution of an exclusive distributor agreement with Implant Sciences
Corporation (AMEX: IMX) for the marketing, distribution, and service of Implant's
revolutionary Quantum Sniffer handheld and desktop explosives detection
equipment. The Quantum Sniffer will be distributed through the Homeland
Integrated Security Systems CyberNoze security division. HISC has taken delivery
of units for introduction into its exclusive territory of Lebanon, and will seek
to expand the geographic presence of the CyberNoze promoted explosives detection
product throughout the Middle East.
Implant's Quantum Sniffer technology is clearly differentiated from competitive
products as a result of being a non-contact device that detects most explosives
vapors directly, as opposed to hand wiping of all trace explosives particles, as
competitive products presently do. In countries such as Lebanon, having regional
instability and anti-terrorism issues, CyberNoze will promote this technology
for use in the detection of trace residues of explosives materials for aviation
and transportation security, protection of high threat facilities,
infrastructure, customs and border protection, and cargo screening.
Dr. Anthony J. Armini, PhD., CEO of Implant Sciences, commented, "We are pleased
to form this alliance with Homeland Integrated Security Systems which will
facilitate the introduction and distribution of our explosives detection
technology through the CyberNoze division. This alliance will broaden the reach
of distribution into international territories considered to be at a high risk
to threat of terrorist attacks."
Mr. Frank A. Moody II, CEO of Homeland Integrated Security Systems, stated, "We
believe Implant has a trace detection technology which is considerably different
from the competition, and is rapidly gaining exposure in the international arena
as a superior explosives detection product offering. We anticipate rapid
acceptance of this important security product through our CyberNoze distribution
channels in Lebanon which could lead to significant orders."
Mr. Moody further commented, "With the recently announced appointment of Barry
Bennett to head our Homeland Security Advisory Board, we believe CyberNoze is
also poised to further promote the Quantum Sniffer based explosives detection
products within the U.S. Homeland Security marketplace."
About Homeland Security Integrated Systems, Inc.
Homeland Integrated Security Systems owns proprietary technology and patent
rights to innovative and sophisticated security products for national and
international security and industry. Among the key target markets are the 361
commercial seaports in the U.S. which are vulnerable to criminal penetration.
The Company is now accepting pre-orders for the Cyber Tracker at
www.hissusa.com.
About Implant Sciences
Implant Sciences, incorporated in 1984, is using its core ion technology to
develop, manufacture and market products for the homeland security,
semiconductor and medical device industries. The Company has developed and
commercialized portable and bench-top trace element detection devices to
identify explosives. In addition, to its other cancer treatment products the
Company recently received an FDA 510k approval for its new radioactive source
for the use in the treatment of breast cancer. For further details on the
Company and its products please visit the Company's website at
www.implantsciences.com.
SOURCE: Homeland Integrated Security Systems, Inc.
By Staff
CONTACT: Homeland Integrated Security Systems
Matt Maguire
866-843-2775 (1-866-THE-APPL)
. |
